Guardian Pharmacy Services, Inc.
GRDN
$29.28
-$0.06-0.20%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.61% | 4.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.61% | 4.56% | |||
| Cost of Revenue | 9.60% | 4.24% | |||
| Gross Profit | 9.65% | 5.90% | |||
| SG&A Expenses | 8.96% | 3.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.50% | 4.19% | |||
| Operating Income | 12.08% | 13.36% | |||
| Income Before Tax | 32.13% | -3.96% | |||
| Income Tax Expenses | 87.18% | -1.90% | |||
| Earnings from Continuing Operations | 8.68% | -4.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 10.84% | 16.00% | |||
| Net Income | 8.73% | -4.42% | |||
| EBIT | 12.08% | 13.36% | |||
| EBITDA | 10.55% | 10.77% | |||
| EPS Basic | 8.59% | -4.46% | |||
| Normalized Basic EPS | 13.66% | 12.63% | |||
| EPS Diluted | 4.97% | -4.86% | |||
| Normalized Diluted EPS | 13.39% | 12.14% | |||
| Average Basic Shares Outstanding | 0.13% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||